Stephens initiated coverage on Pacific Biosciences with a new price target

12/14/23 7:43:16 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Stephens initiated coverage of Pacific Biosciences with a rating of Overweight and set a new price target of $11.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PACB

Date	Price Target	Rating	Analyst
11/11/2024		Buy → Neutral	UBS
6/3/2024	$4.00	Buy	Jefferies
4/22/2024		Overweight → Neutral	JP Morgan
4/18/2024	$7.00 → $2.50	Buy → Neutral	Goldman
12/14/2023	$11.00	Overweight	Stephens
12/14/2023		Neutral	Guggenheim
12/13/2023		Peer Perform	Wolfe Research
11/17/2023	$13.00 → $10.00	Neutral → Buy	UBS